Evidence map›Paper›PMID 40224710›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2025

Daily Versus Alternate Day Oral Iron Replacement for Women with Iron Deficiency Anaemia: A Randomized Controlled Trial.

Mallesh Dhanush, Kolar Vishwanath Vinod, Prabhu Manivannan, Prashant S Adole, Dhanajayan Govindan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Iron Deficiency anemia Therapy: Hepcidin, Dosing, Formulations and Adjuvants.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mallesh DhanushDepartment of General Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research [JIPMER], Dhanvantri Nagar, Puducherry, Pondicherry, 605006 India.
Kolar Vishwanath VinodDepartment of General Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research [JIPMER], Dhanvantri Nagar, Puducherry, Pondicherry, 605006 India.ORCID 0000-0002-2762-1048
Prabhu ManivannanDepartment of Pathology, JIPMER, Dhanvantri Nagar, Puducherry, Pondicherry, 605 006 India.ORCID 0000-0001-8247-3343
Prashant S AdoleDepartment of Biochemistry, JIPMER, Dhanvantri Nagar, Puducherry, Pondicherry, 605006 India.ORCID 0000-0002-1692-3892
Dhanajayan GovindanDepartment of Community Medicine, JIPMER, Dhanvantri Nagar, Puducherry, Pondicherry, 605006 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The optimal way of oral iron replacement for iron deficiency anaemia(IDA) is still unknown and few recent studies have reported better fractional absorption and tolerability of intermittently administered iron. This randomised, active comparator controlled, open-label trial evaluated efficacy and tolerability of 120 mg elemental iron (2 × 200 mg ferrous sulphate tablets) administered as a single dose on alternate days (alternate-day arm, ADA) vis-à-vis 60 mg elemental iron (single FeSO

Indexed as

Adverse effectsAlternate-day dosingIron deficiency anaemiaOral iron replacementSerum hepcidinTreatment compliance

Identifiers

PMID40224710
PMCPMC11992272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.